Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Annovis Bio (ANVS) is now available.
Annovis Bio, Inc. has successfully exercised 0.8 million warrants issued in November 2023, resulting in a capital boost of $7.0 million through the issuance of roughly the same number of common shares. The transactions, which took place between July 8 and 9, 2024, were priced at $9.00 per share. This move represents a significant financial milestone for the company, reflecting investor confidence and providing funds for future endeavors.
Find detailed analytics on ANVS stock on TipRanks’ Stock Analysis page.
